Last Updated on January 5, 2024 by The Health Master
The U.S. Food and Drug Administration (USFDA) has issued a Form 483 with four observations to Aurobindo Pharma after inspecting the company’s (Unit XIV) active pharmaceutical ingredient manufacturing facility in Andhra Pradesh.
The API non-antibiotic manufacturing facility in Paravada Industrial Area, Anakapalli district, was inspected from May 15-19.
“We have been issued a Form 483 with four observations [which] are procedural in nature,” Aurobindo said.
The company said it will respond within the stipulated timelines and work closely with regulator to close the observations at the earliest.
On Friday, Aurobindo shares closed 1.64% lower at ₹589.45 each on the BSE.
USFDA issues Form 483 with zero observations to Pharma MSMEs: Gujarat
USFDA issues Form 483 with 3 observation to Zydus, Ahmedabad
USFDA issues Form 483 with zero observation to Piramal
USFDA issues Form 483 with 10 observations to Lupin, Pithampur
USFDA issues Form 483 with 2 observations to Alembic, Gujarat
USFDA issues Form 483 with 3 observations to Bliss GVS Pharma, Maharashtra
8th Edition of ‘India Pharma and India Medical Device 2023’ Conference
PCI to introduce Pharmacy Practical Training for D Pharm student
USFDA gives EIR Strides Pharma, Puducherry
NPPA fixed Ceiling price of 5 scheduled formulations: May 2023
NPPA revised Ceiling price of 15 scheduled formulations: May 2023
Pharma Industry seek price ceiling exemption for low cost drugs
One more arrest in Spurious Pharma Raw Material case
NPPA fixed retail price of 15 formulations: May 2023
Revising DT limit for Soft Gelatin Capsules: Pharma Industry seek solutions
Drug alert: 36 out of 895 samples declared as NSQ in April 2023
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
